Could Psilocybin Prevent Chemotherapy-Induced Neuropathy?
Chemotherapy can save lives, but it can also damage nerves.
For some cancer patients, that nerve damage starts as tingling or numbness in the fingers and toes. For others, it can become burning pain, extreme sensitivity to cold, balance problems, or loss of feeling. These symptoms are known as chemotherapy-induced peripheral neuropathy, or CIPN.
Neuropathy can sometimes last long after chemotherapy ends. In severe cases, doctors may even need to delay treatment, lower the chemotherapy dose, or change treatment because the nerve damage has become too serious.
Now researchers at The University of Texas MD Anderson Cancer Center are studying an unexpected way to prevent that damage: psilocybin, the psychedelic compound found in certain mushrooms.
A new study published in Science on September 3, 2026, found that psilocybin given before chemotherapy protected nerves and prevented symptoms of peripheral neuropathy in several preclinical models. The protection continued even through repeated cycles of chemotherapy.
The results are promising.
But there is an important point to understand right away:
This research was conducted in preclinical models, not cancer patients. Psilocybin has not been proven to prevent chemotherapy-induced neuropathy in humans.
A Phase 2 clinical trial is planned to find out whether the same approach can help people undergoing chemotherapy.
What Is Chemotherapy-Induced Peripheral Neuropathy?
Peripheral nerves carry information between your brain, spinal cord, skin, muscles, and other parts of your body.
Some chemotherapy drugs can damage these nerves.
When this happens, patients may experience:
Tingling or a "pins and needles" feeling
Numbness in the hands or feet
Burning or shooting pain
Increased sensitivity to cold
Trouble feeling heat, cold, or pressure
Muscle weakness
Balance problems
Difficulty walking or performing everyday tasks
The National Cancer Institute notes that neuropathy may continue even after cancer treatment has ended.
Several commonly used cancer drugs can cause neuropathy. These include platinum chemotherapy drugs such as cisplatin and oxaliplatin and taxanes such as paclitaxel and docetaxel.
That creates a difficult problem.
The chemotherapy may be successfully attacking the cancer while also damaging healthy nerves.
Why Is Chemotherapy Neuropathy So Difficult to Prevent?
Doctors have ways to manage some chemotherapy side effects.
For example, medications can help control nausea. Other supportive treatments can help patients manage diarrhea, dehydration, mouth sores, and other complications.
Neuropathy is harder.
An American Society of Clinical Oncology guideline concluded that there is currently no medication recommended for routine prevention of chemotherapy-induced peripheral neuropathy. Duloxetine has evidence supporting its use for some patients who already have painful CIPN, but its benefit is limited.
When neuropathy becomes severe, doctors may have to consider:
Delaying chemotherapy
Reducing the chemotherapy dose
Switching drugs
Stopping the nerve-damaging treatment
That is one reason researchers are especially interested in preventing nerve damage before it happens.
What Is Psilocybin?
Psilocybin is a naturally occurring psychedelic substance found in certain types of mushrooms.
Most research involving psilocybin has focused on the brain and mental health. Scientists have studied it for conditions such as depression, anxiety, and other psychiatric or neurologic disorders.
The MD Anderson researchers looked at something different.
They wanted to know whether psilocybin could directly protect nerves from the physical damage caused by chemotherapy.
Their results suggest that it might.
What Did the New Psilocybin Study Find?
Researchers tested psilocybin in several preclinical models of chemotherapy-induced neuropathy.
They found that as few as two doses of psilocybin given before chemotherapy prevented several signs of nerve injury.
The treatment:
Reduced abnormal sensitivity to cold
Protected sensory nerve endings
Helped preserve normal touch sensation
Continued working through repeated chemotherapy cycles
Did not appear to interfere with chemotherapy's ability to attack tumors in the models studied
Researchers saw protective effects with several chemotherapy drugs, including cisplatin, paclitaxel, and docetaxel.
That last point is particularly important.
Any treatment designed to protect healthy cells during chemotherapy has to answer a critical question:
Does it also protect the cancer?
In these preclinical models, researchers reported that psilocybin's nerve-protecting effect did not reduce the antitumor activity of chemotherapy.
Again, that does not prove the same thing will happen in humans. That question will require clinical trials.
How Might Psilocybin Protect Nerves?
This may be the most interesting part of the research.
The study suggests psilocybin was not simply blocking the feeling of pain.
It appeared to be helping protect the nerves themselves.
To understand how, we need to talk about mitochondria.
Think of Mitochondria as Tiny Power Plants
Almost every cell in your body needs energy.
Inside those cells are tiny structures called mitochondria. Their job is to help produce that energy.
Nerve cells are especially challenging because they can be very long. Some nerves stretch from your spinal cord all the way to your feet.
That means the cell has to move mitochondria to the places where energy is needed.
Think of it like supplying fuel to towns along a very long highway.
If the fuel trucks stop moving, communities at the end of the highway start running out of power.
Researchers found that cisplatin disrupted the movement and distribution of mitochondria inside nerve fibers. The nerve endings were essentially being deprived of an important source of energy.
Psilocybin appeared to help keep those mitochondria moving.
The Role of the Serotonin 5-HT2A Receptor
Researchers traced much of psilocybin's protective effect to a serotonin receptor called 5-HT2A.
Serotonin is a chemical messenger that helps cells communicate.
When researchers blocked this receptor, psilocybin's nerve-protecting benefits disappeared.
When they used another compound that activated the same receptor, they again saw nerve protection.
That finding could be important for another reason.
The second compound was non-hallucinogenic.
In other words, researchers may eventually be able to target the same biological pathway without necessarily producing the psychedelic effects associated with psilocybin.
That possibility is still experimental, but it could open an entirely new area of research into preventing chemotherapy-related nerve damage.
Prevention vs. Treating the Pain Later
This study also takes a different approach to neuropathy.
Most treatments are used after neuropathy appears.
Researchers here are asking:
What if we protect the nerves before chemotherapy damages them?
That is an important distinction.
Once severe nerve damage develops, it may take months or years to improve, and some patients may continue to have symptoms long after cancer treatment ends.
Preventing that injury could potentially be much more useful than trying to manage the symptoms afterward.
But researchers first need to prove that the protection seen in preclinical models also occurs safely in humans.
Will Psilocybin Be Tested in Cancer Patients?
Yes.
MD Anderson has registered a Phase 2 clinical study called NeuroGuard to evaluate psilocybin for preventing or reducing chemotherapy-induced peripheral neuropathy.
The trial is listed as NCT07227909 on ClinicalTrials.gov.
The study plans to evaluate people receiving nerve-damaging chemotherapy for:
Breast cancer
Colorectal cancer
Head and neck cancers
Patients receiving taxane- or platinum-based chemotherapy are among those being studied.
Researchers plan to compare psilocybin with placebo and standard supportive care.
They will examine whether psilocybin can reduce the incidence or severity of neuropathy and whether preventing neuropathy can reduce chemotherapy dose changes caused by nerve toxicity.
As of the latest ClinicalTrials.gov record reviewed for this article, the study was listed as not yet recruiting.
Does This Mean Cancer Patients Should Take Psilocybin?
No.
This study does not show that cancer patients should take psilocybin on their own before chemotherapy.
The research published in Science was preclinical.
Scientists still need to answer important questions in people, including:
What dose is safe?
When should it be given?
How often should it be given?
Does it work with different chemotherapy drugs?
Does it prevent neuropathy in humans?
Are there patients who should not receive it?
Could it interact with medications or medical conditions?
Does it continue to leave cancer treatment effectiveness unchanged?
Those are exactly the kinds of questions clinical trials are designed to answer.
Patients should not use psilocybin to prevent or treat chemotherapy side effects unless it is part of appropriate medical care or a clinical study supervised by qualified healthcare professionals.
Why This Research Matters
The interesting part of this study goes beyond psilocybin.
It points toward a broader change in supportive cancer care.
The goal of cancer treatment is to attack the cancer.
But doctors and researchers are also trying to find better ways to protect healthy tissues while treatment is doing its job.
Chemotherapy can affect healthy systems throughout the body, including:
Nerves
The digestive tract
The mouth
Bone marrow
Skin
Hair
Muscles
Other organs and tissues
Some of these side effects can affect whether a patient is able to continue treatment as planned.
Neuropathy is a good example.
If nerve damage becomes severe enough, the treatment intended to fight the cancer may need to be reduced or delayed.
A therapy that safely prevents this damage without weakening chemotherapy could therefore have value beyond simply reducing discomfort.
It could potentially help patients tolerate the treatment they need.
That is why the upcoming human research will be worth watching closely.
What Should Patients With Neuropathy Do Now?
Patients who notice numbness, tingling, burning, cold sensitivity, weakness, or changes in balance during chemotherapy should tell their cancer care team.
Don't assume neuropathy is something you simply have to endure.
Your healthcare team may need to evaluate your symptoms and determine whether changes in your cancer treatment or supportive care are appropriate.
The National Cancer Institute also recommends taking precautions because loss of sensation can increase the risk of burns, cuts, and falls.
Most importantly, don't wait until symptoms become severe before mentioning them.
The Bottom Line
A new MD Anderson study published in Science found that psilocybin given before chemotherapy prevented chemotherapy-induced peripheral neuropathy in several preclinical models.
Researchers found that psilocybin appeared to protect nerve cells by activating serotonin receptors and preserving the movement of energy-producing mitochondria inside the nerves. The effect was seen with several chemotherapy drugs and did not appear to reduce chemotherapy's antitumor activity in the models studied.
Those results are exciting, but they are not yet evidence that psilocybin prevents neuropathy in cancer patients.
The next major question is whether the same nerve protection can be safely reproduced in humans.
A Phase 2 clinical trial is designed to begin answering that question.
For now, psilocybin should be viewed as a promising area of cancer supportive-care research—not an established treatment for chemotherapy-induced neuropathy.
Frequently Asked Questions
What is chemotherapy-induced peripheral neuropathy?
Chemotherapy-induced peripheral neuropathy, or CIPN, is nerve damage caused by certain chemotherapy drugs. Symptoms can include tingling, numbness, burning pain, cold sensitivity, weakness, and balance problems, usually beginning in the hands or feet.
Which chemotherapy drugs can cause neuropathy?
Several chemotherapy drugs can cause peripheral neuropathy. Common examples include platinum drugs such as cisplatin and oxaliplatin and taxanes such as paclitaxel and docetaxel. Other cancer treatments can also damage peripheral nerves.
Can chemotherapy neuropathy become permanent?
It can. Neuropathy sometimes improves after chemotherapy stops, but symptoms can continue for months or years in some patients. Severe nerve damage may not fully resolve.
Can psilocybin prevent chemotherapy neuropathy?
We don't know yet. Psilocybin prevented neuropathy in preclinical models in a 2026 MD Anderson study, but it has not yet been proven to prevent CIPN in humans. A Phase 2 clinical trial is being conducted to study the question.
How does psilocybin appear to protect nerves?
Researchers found that psilocybin activated serotonin 5-HT2A receptors and helped preserve the movement of mitochondria inside nerve fibers. Mitochondria provide energy to cells, and keeping them properly distributed may help nerve endings survive the stress caused by chemotherapy.
Did psilocybin interfere with chemotherapy?
In the preclinical models studied, researchers reported that psilocybin preserved nerve function without reducing chemotherapy's antitumor activity. Human trials are still needed to determine whether this is also true in patients.
Is psilocybin approved to treat chemotherapy-induced neuropathy?
No. Psilocybin is not an approved treatment for preventing chemotherapy-induced peripheral neuropathy. Its use for this purpose remains experimental.
Is there a treatment that prevents chemotherapy-induced neuropathy?
Current ASCO guidance does not recommend a medication proven to routinely prevent CIPN. Duloxetine has evidence supporting its use for some patients who already have painful chemotherapy-induced neuropathy, but its benefit is limited.
What should I do if I develop numbness or tingling during chemotherapy?
Tell your oncology team as soon as possible. Your healthcare provider can evaluate the symptoms and determine whether treatment changes, medications, safety precautions, or other supportive measures are appropriate.
References
For more information on how HuMOLYTE can support your gut health during chemotherapy, visit our product page or consult your health care provider.
This blog was reviewed by Dr. Sourabh Kharait.
This blog is for educational purposes only and is not intended as medical advice. Always consult with your healthcare provider before making any changes to your treatment plan, hydration strategies, or diet. The information provided here is based on general insights and may not apply to individual circumstances.
